1. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A, HPV DNA testing of self-collected vaginal

samples compared with cytologic screening to detect cervical cancer . JAMA. 2000 Jan 5;283(1):81­6.

2. Saslow D, Runowicz CD , Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society 

guideline for the  early detection  of cervical neoplasia  and  cancer. CA Cancer J  Clin  2002 Nov­ Dec;52(6):342­62.

 

3. Crum CP. Symposium part1: Should  the Bethesda System terminology be  used in diagnostic surgical

pathology?: Point. Int J Gynecol Pathol 2003 Jan;22(1):5­12.

4. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human  papillomavirus­based and other novel options for cervical cancer screening in developed and developed 

and developing countries. Vaccine 2008 Aug 19;26(Suppl 10): K29­41.

5. Goel MM, Mehrotra A, Singh U, Gupta HP,Misra JS. MIB­1 and PCNA immunostaining as a diagnostic  adjunct to cervical pap smear. Diagn Gytopathol 2005 Jul;33(1):15­9.

6. Xue Y, Feng Y, Zhu G, Zhang X. Proliferative activity in  cervical intraepithelial neoplasia and  cervical carcinoma. Chin Med J(Engl )1999 Apr;112(4):373­5.

7. Stoler MH, Schiffman  M, Stoler MH,  Schiffman  M; Atypical Squamous Cells of Undetermined 

Significance­Low­grade  Squamous Intraepithelial Lesion  Triage Study (ALTS) Group. Interobserver

reproductbility of cervical cytologic and  histologic interpretations: realistic estimates  from the ASCUS­ 

LSIL Triage Study. JAMA 2001 Mar 21;285(11):1500­5.

8. Meyer JS, Connor RE. In  vitro labeling of solid tissues with tritiated thymidine for autoradiographic  detection of S­phase nuclei. Stain Technol 1977 Jul;52(4):185­95.

9. Tjalma W, Weyler J, Pollefliet C, Bogers  J,  Van  Marck  E,  Van  Dam P, et al. The evaluation  of

proliferative activity in CIN III and microinvasive cervical cancer and its role in recurrence. Eur J Obstet

Gyencol Reprod Biol 2001 Feb:94(2):270­5.

10. Lee KR, Sun D, Crum CP. Endocervical intraepithelial glandular atypia  (dysplasia ): a histopathologic, human papillomavirus, and MIB­1 analysis of 25 cases. Hum Pathol 2000 Jun;31(6):656­64.

11. Wang JL, Zheng BY, Li XD, Angstrom T, Lindstrom MS, Wallin  KL. Predictive  significance  of the  alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression  of cervical cancer. Clin Cancer Res 2004 Apr 1;10(7):2407­14.

12. Cuzick J, Mayrand MH, Ronco G, Snijders P, Wardle J. Chapter 10: New dimensions in cervical cancer screening. Vaccine 2006 Aug 31;24( Suppl 3):S3/90­7.

13. Bar JK, Harlozinska A, Sedlaczek P, Kasiak J, Markowska J. Relations between the expression of p53, c­ erB­2, Ki­67 and HPV infection in cervical carcinomas and cervical dysplasias. Anticancer Res 2001 Mar­ Apr;21(2A):1001­6.

14. Beneder JL, Bender H, Jones  H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications  and clinical

practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

Int J Gynecol Obstet 2000 Aug;70(2):209­62.

15. Sanchez­Rosales M, Osorio­Morales S, Diaz­Araujo F. [Evaluation of the inmunohistochemical markers  PCNA and MIB­1 in the diagnosis of low grade lesions of the uterine cervix]. [Article in Spanish]. Invest

Clin 2004 Sep;45(3):213­20.

16. Kuo KT, Chang HC, Hsiao CH, Lin MC. Increased Ki­67 proliferative index and absence of P16INK4 in  CIN­HPV related pathogenic pathways  different from cervical squamous intraepithelial lesion. Br J 

Ophthalmol 2006 Jul;90(7):894­9.

17. al­Saleh W, Delvenne P, van den Brulet FA, Menard S, Boniver J, Castronovot V. Expression of the 67 

KD laminin  receptor in  human cervical preneoplastic and  neoplastic squamous  epithelial lesions: an 

immunohistochemical study. J Pathol 1997 Mar;181(3):287­93.

18. Saha B, Chaiwun B, Tsao–Wei DD, Groshen SL, Naritoku WY, Atkinson  RD, et al. Telomerase and  markers of cellular proliferation  are  associated with the progression  of cervical intraepithelial neoplasia 

lesion. Int J Gyencol Pathol 2007 Jul;26(3):214­22.

19. Pirog EC, Baergen RN, Soslow RA, Tam D, DeMattia AE, Chen YT, et al. Diagnostic accuracy of cervical

low­grade squamous Intraepithelial lesions is  improved  with MIB­1  immunostaining. Am J  Surg Pathol

2002 Jan;26(1):70­5.

20. Erfanian M, Sharifi N, Omidi AA. [P63  and Ki67 expression in trophoblastic disease and sponotaneous  abortion. [Article in Persian]. JRMS 2009 Sept­Oct;l14(5): 23­32.